Did not become law. It stopped in the House of Representatives's Health Care Committee on July 8, 2013. The 2013 session has ended.
2013 Regular Session
House Bill 2705
Restricts substitution of biosimilar product for prescribed biological product.
What it does
The synopsis the Legislative Assembly published with the bill.
Restricts substitution of biosimilar product for prescribed biological product. Becomes operative on January 1, 2014. Declares emergency, effective on passage.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the House of Representatives
Sponsor
Chief co-sponsor
In the Senate
Sponsor
Chief co-sponsor
Its course
February 4 to July 8, 2013, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action3 actions on 3 days
In the House of RepresentativesFeb 4 to Jul 8 · stopped154 days
Waiting for a committeeFeb 4 to Feb 117 days
Health CareFeb 11 to Jul 8 · stopped147 days
Text
Each version as the Legislative Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the Legislative Assembly published it is below.
In the House of Representatives Feb 4 – Jul 8
- Feb 4Introduced
- Feb 11Sent to Health Care
- Jul 8Died when the session ended
All 3 actions, as published
- Feb 4First reading. Referred to Speaker's desk.House of Representatives
- Feb 11Referred to Health Care.House of Representatives
- Jul 8In committee upon adjournment.House of Representatives